Syneos Health, a fully integrated biopharmaceutical solutions organization, completed the acquisition of a minority stake in Indegene Omnipresence, a customer engagement transformation platform for the life sciences industry. Financial terms were not disclosed. "The biopharmaceutical industry is under growing pressure to deliver value-based customer experiences in a far more competitive marketplace. Omnipresence offers customers a bold new choice – an innovative platform, underpinned by Microsoft technologies, to drive intelligent commercial relationships. The next-generation solution will enable customers to harness data to provide actionable insights and realize better commercial experiences, with improved return on investment," Alistair Macdonald, Syneos Health CEO.